Detalhe da pesquisa
1.
OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza.
Front Immunol
; 12: 678483, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34177921
2.
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Front Immunol
; 12: 694759, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34335606
3.
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes.
NPJ Vaccines
; 4: 4, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30701093
4.
The oligomerization domain of C4-binding protein (C4bp) acts as an adjuvant, and the fusion protein comprised of the 19-kilodalton merozoite surface protein 1 fused with the murine C4bp domain protects mice against malaria.
Infect Immun
; 76(8): 3817-23, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18474650
5.
Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.
Front Immunol
; 8: 1998, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29403479
6.
MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation.
PLoS One
; 11(5): e0154705, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27228181
7.
Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
PLoS One
; 11(2): e0148840, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26871712
8.
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Vaccine
; 34(11): 1412-21, 2016 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26854906
9.
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.
Sci Rep
; 6: 18848, 2016 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26743316
10.
Solid-state NMR sequential assignments of the C-terminal oligomerization domain of human C4b-binding protein.
Biomol NMR Assign
; 8(1): 1-6, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23138856
11.
Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
PLoS One
; 7(3): e33555, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22470455
12.
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.
PLoS One
; 7(9): e44943, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22984589
13.
Effective induction of high-titer antibodies by viral vector vaccines.
Nat Med
; 14(8): 819-21, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18660818